Anderson 1986.

Methods	Randomization: no details Allocation concealment: no details Blinding: single (placebo and vaccine looked similar) Data collection: no details Intention to treat: yes Interim analysis: none Exclusion from analysis: none Follow‐up period: 8 days after vaccination
Participants	Age: 8 to 60 months Health status: healthy Breastfeeding: 50 to 75% Immunization status: no information Clinical symptoms: clinical evaluation, no further details Laboratory studies: serology and stool analysis by ELISA
Interventions	1. Rhesus vaccine (MMU 18006), 10^6.5 PFU single dose (n = 13) 2. Placebo (similac formula), 30 ml single dose (n = 10) 30 ml similac formula given with vaccine or placebo
Outcomes	1. Safety: clinical symptoms within 8 days
Notes	Study location: USA Two separate trials